S118: A carcinoma in situ of the ileum - a rare tumor entity of the neobladderThe open prostatectomy is the oldest method for the surgical treatment of benign prostate enlargement. The surgical treatment of these large adenomas comes back into focus, as in patients with mild lower urinary ...
Carcinoma in situ (CIS) is associated with increased risk of progression when found with high-grade non-muscle-invasive bladder cancer, yet its impact is less clear in the upper urinary tract. In the current study, we evaluated the impact of concomitant CIS on recurrence-free survival and canc...
Method: In this context, we present the case of a 44-year-old patient with a 7-month history of cervical swelling. Results: After diagnostic extirpation of the tumor, histologic findings were consistent with a lateral branchial cyst with high-grade dysplasia and carcinoma in situ of the ...
is a fiction!]]>in situ is a fiction!]]>doi:10.1111/j.1600-0560.2008.00984.xView Full Article (HTML) Get PDF (41K) More content like this Find more content: like this article Find more content written by:A. Bernard AckermanJoan MonesAll Authors ABOUT USHELPCONTACT USAGENTSADVERTISERS...
Phyllodes tumor (PT) is an uncommon tumor of female breast. The tumor clinically, radiologically, cytologically as well as histologically can mimic fibroadenoma which is a common tumor of fibroepithelial group. Ductal carcinoma in situ (DCIS) in the epithelial component of PT is very rare. We...
SF Shariat,GS Palapattu,PI Karakiewicz,CG Rogers,A Vazina,PJ Bastian,MP Schoenberg,SP Lerner,AI Sagalowsky,Y Lotan.Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. European Urology . 2007...
she had what's called a ductcal carcinoma in situ -- or a tumor in the milk gland. However, it was caught early -- was only about 2.5 cm (or about the size of a US quarter) and had clear margins. She had a modified radical mastectomy and 26 years later, is still cancer-free,...
Molecular stratification can improve the management of advanced cancers, but requires relevant tumor samples. Metastatic urothelial carcinoma (mUC) is poised to benefit given a recent expansion of treatment options and its high genomic heterogeneity. We profile minimally-invasive plasma circulating tumor DN...
Clinical prognostic factors for recurrence and progression are size, multiplicity, reaction to intravesical therapy, grade, stage, and the presence of carcinoma in situ. In addition, recurrence anywhere in the bladder at first FU cystoscopy after transurethral resection is one of the most important ...
摘要: Introduction The term "intracystic papillary ductal carcinoma in situ" has recently changed and is now more appropriately referred to "intracystic papillary carcinoma". Intracystic papillary...关键词: Medicine(General DOI: 10.1186/1752-1947-3-13 被引量: 66 ...